J&J Beats Q3 Earnings Estimates, Raises Full-Year Outlook After Spinoff

J&J lifts full-year guidance after Q3 earnings beat expectations

First earnings report since spinning off Kenvue business

J&J stock rises on raised outlook

Q3 earnings top forecasts driven by pharmaceutical sales

Company cites strong performance across segments like consumer health